Dilan Athauda

3.9k total citations · 1 hit paper
31 papers, 2.4k citations indexed

About

Dilan Athauda is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Dilan Athauda has authored 31 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Neurology, 11 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Dilan Athauda's work include Parkinson's Disease Mechanisms and Treatments (25 papers), Diabetes Treatment and Management (11 papers) and Neurological disorders and treatments (10 papers). Dilan Athauda is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (25 papers), Diabetes Treatment and Management (11 papers) and Neurological disorders and treatments (10 papers). Dilan Athauda collaborates with scholars based in United Kingdom, United States and Sweden. Dilan Athauda's co-authors include Thomas Foltynie, Simon S. Skene, Kashfia Chowdhury, Patricia Limousin, Yazhou Li, Nigel H. Greig, Steve Hibbert, Luca Zampedri, Icíar Avilés-Olmos and Kate Maclagan and has published in prestigious journals such as The Lancet, Brain and Journal of Neurochemistry.

In The Last Decade

Dilan Athauda

31 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

2017 603 citations Dilan Athauda, Kate Maclagan et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dilan Athauda United Kingdom	19	1.3k	722	663	636	488	31	2.4k
Chandramohan Wakade United States	27	423 0.3×	501 0.7×	242 0.4×	738 1.2×	340 0.7×	43	2.2k
Masakazu Ibi Japan	25	372 0.3×	550 0.8×	236 0.4×	627 1.0×	482 1.0×	46	2.2k
Kuen‐Jer Tsai Taiwan	28	936 0.7×	360 0.5×	142 0.2×	1.1k 1.7×	744 1.5×	77	2.9k
Corinne G. Jolivalt United States	24	304 0.2×	413 0.6×	278 0.4×	462 0.7×	1.1k 2.3×	41	1.8k
Jon Infante Spain	34	1.0k 0.8×	970 1.3×	89 0.1×	1.1k 1.7×	748 1.5×	156	3.0k
Per‐Göran Gillberg Sweden	31	420 0.3×	649 0.9×	144 0.2×	704 1.1×	885 1.8×	79	2.6k
Liying Han China	21	256 0.2×	540 0.7×	347 0.5×	943 1.5×	1.4k 2.9×	51	3.2k
Cyntia Tremblay Canada	27	381 0.3×	584 0.8×	131 0.2×	748 1.2×	1.5k 3.0×	57	2.6k
J. Scott Miners United Kingdom	36	738 0.6×	497 0.7×	185 0.3×	937 1.5×	2.0k 4.0×	68	3.8k
Wenjie Xie China	23	822 0.6×	723 1.0×	83 0.1×	687 1.1×	329 0.7×	55	2.1k

Countries citing papers authored by Dilan Athauda

Since Specialization

Citations

This map shows the geographic impact of Dilan Athauda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilan Athauda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilan Athauda more than expected).

Fields of papers citing papers by Dilan Athauda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilan Athauda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilan Athauda. The network helps show where Dilan Athauda may publish in the future.

Co-authorship network of co-authors of Dilan Athauda

This figure shows the co-authorship network connecting the top 25 collaborators of Dilan Athauda. A scholar is included among the top collaborators of Dilan Athauda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilan Athauda. Dilan Athauda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Athauda, Dilan, et al.. (2023). Intelligent Motion Planning for Collision Free Autonomous Docking of Satellite Emulation Platform Using Reinforcement Learning. IFAC-PapersOnLine. 56(2). 3354–3359. 3 indexed citations

D’Sa, Karishma, James R. Evans, Gurvir S. Virdi, et al.. (2023). Prediction of mechanistic subtypes of Parkinson’s using patient-derived stem cell models. Nature Machine Intelligence. 5(8). 933–946. 11 indexed citations

Athauda, Dilan, James R. Evans, Anna I. Wernick, et al.. (2022). The Impact of Type 2 Diabetes in Parkinson's Disease. Movement Disorders. 37(8). 1612–1623. 66 indexed citations

Girges, Christine, Nirosen Vijiaratnam, Dilan Athauda, et al.. (2021). The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability. Drugs & Aging. 38(5). 355–373. 13 indexed citations

Jabbari, Edwin, John Woodside, Tong Guo, et al.. (2019). Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. Journal of Neurology Neurosurgery & Psychiatry. 90(7). 768–773. 39 indexed citations

Foltynie, Thomas & Dilan Athauda. (2019). Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience. Progress in brain research. 252. 493–523. 33 indexed citations

Burrows, Maggie, Dilan Athauda, Bruce Hellman, et al.. (2019). The BRadykinesia Akinesia INcoordination (BRAIN) Tap Test: Capturing the Sequence Effect. Movement Disorders Clinical Practice. 6(6). 462–469. 23 indexed citations

Dayal, Viswas, Elina Tripoliti, Dilan Athauda, et al.. (2019). Short Versus Conventional Pulse‐Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison. Movement Disorders. 35(1). 101–108. 18 indexed citations

Athauda, Dilan, Kate Maclagan, Natalia Budnik, et al.. (2018). Post hoc analysis of the Exenatide‐ PD trial—Factors that predict response. European Journal of Neuroscience. 49(3). 410–421. 57 indexed citations

10.

Foltynie, Thomas & Dilan Athauda. (2018). Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies Treatment. Movement Disorders Clinical Practice. 5(3). 255–258. 7 indexed citations

11.

Athauda, Dilan, Natalia Budnik, Kashfia Chowdhury, Simon S. Skene, & Thomas Foltynie. (2018). The effect of exenatide on specific non-motor symptoms in Parkinson’s disease – a post-hoc analysis.. Surrey Research Insight Open Access (The University of Surrey). 1 indexed citations

12.

Athauda, Dilan, Richard Wyse, Patrik Brundin, & Thomas Foltynie. (2017). Is Exenatide a Treatment for Parkinson’s Disease?. Journal of Parkinson s Disease. 7(3). 451–458. 31 indexed citations

13.

Athauda, Dilan, Kate Maclagan, Simon S. Skene, et al.. (2017). Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial. The Lancet. 390(10103). 1664–1675. 603 indexed citations breakdown →

14.

Athauda, Dilan & Thomas Foltynie. (2017). Protective effects of the GLP-1 mimetic exendin-4 in Parkinson's disease. Neuropharmacology. 136(Pt B). 260–270. 79 indexed citations

15.

Athauda, Dilan & Thomas Foltynie. (2016). Challenges in detecting disease modification in Parkinson's disease clinical trials. Parkinsonism & Related Disorders. 32. 1–11. 53 indexed citations

16.

Athauda, Dilan & Thomas Foltynie. (2016). Insulin resistance and Parkinson’s disease: A new target for disease modification?. Progress in Neurobiology. 145-146. 98–120. 247 indexed citations

17.

Athauda, Dilan, et al.. (2014). Clinically silent idiopathic Parkinson’s disease unmasked by valproate use: a brief report. Aging Clinical and Experimental Research. 27(3). 387–390. 6 indexed citations

18.

Athauda, Dilan & Thomas Foltynie. (2014). The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nature Reviews Neurology. 11(1). 25–40. 196 indexed citations

19.

Athauda, Dilan, et al.. (2014). Cerebral air embolism during endoscopic retrograde cholangiopancreatography: treatment with therapeutic hypothermia. Endoscopy. 46(S 01). E151–E152. 7 indexed citations

20.

Athauda, Dilan, et al.. (2013). A SURVEY OF UNDERGRADUATE TEACHING OF CLINICAL NEUROLOGY IN THE UNITED KINGDOM 2012. Journal of Neurology Neurosurgery & Psychiatry. 84(11). e2.13–e2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact